Title of article :
A Bone Marrow Study; Report of Chromosomal Variations in Hematologic Malignancies Including Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodisplastic Syndrome (Northeast Iran)
Author/Authors :
Shakeri, Sepideh Cancer Molecular Pathology Research Center - Mashhad University of Medical Sciences, Mashhad, Iran , Ayatollahi, Hossein Cancer Molecular Pathology Research Center - Mashhad University of Medical Sciences, Mashhad, Iran , Sadeghian, Mohammad Hadi Cancer Molecular Pathology Research Center - Mashhad University of Medical Sciences, Mashhad, Iran , Shams, Fatemeh Transfusion Research Center - High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract :
Background: Chromosomal aberrations which occur in different hematologic
malignancies are believed to be highly applicable for identifying the prognosis and
treatment protocols. We conducted the present study to investigate the chromosomal
and molecular abnormalities in bone marrow of acute myeloid leukemia (AML),
acute lymphoid leukemia (ALL), and myelodysplastic syndrome patients.
Method: We performed this cross-sectional study in molecular pathology and
cancer research center of Mashhad University of Medical Sciences (MUMS), during
2017-2019; the total number of our cases was 252. We did all the molecular and
cytogenetic tests on these patients. SPSS V.16 software was utilized for the analysis
of our data.
Results: In this research, the ALL patients were meaningfully younger than AML
ones. There were significant associations between karyotype patterns and types of
malignancy; normal diploid was more frequent in myelodysplastic syndrome (P<0.05).
Among numerical abnormalities, trisomy 3 and monosomy 14 were the most prevalent
ones.
Conclusion: The results of similar studies from different areas with different
ethnics would help to identify new parameters for prognosis determination. Cytogenetic
analysis is highly applicable for leukemia diagnosis and prognosis.
Keywords :
Chromosome aberrations , Hematology , Cytogenetic analysis , Leukemia
Journal title :
Middle East Journal of Cancer (MEJC)